The US Supreme Court is tackling a question that could have a major impact on biopharma patent owners: Does the sale of a secret invention to a third party trigger the on-sale bar to patenting under the America Invents Act?
In its June 25 orders, the Supreme Court granted Helsinn Healthcare SA's (Helsinn Group) petition for certiorari, Helsinn...





